![]() |
市場調查報告書
商品編碼
2120394
美國生物農藥:市場佔有率分析、行業趨勢和統計數據、成長預測(2026-2031 年)United States Biopesticides - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
據 Mordor Intelligence 稱,2025 年美國生物農藥市值為 18.6 億美元,預計在預測期(2026-2031 年)內將以 12.7% 的複合年成長率成長,從 2026 年的 21 億美元成長到 2031 年的 38.2 億美元。

本報告按形態(生物真菌、生物除草劑等)和作物類型(經濟作物、園藝作物、大田作物)進行分類。市場預測以價值(美元)和數量(公噸)表示。
有機農業的擴張以及消費者對符合殘留物標準的農產品日益成長的需求,正在推動美國生物農藥的普及。儘管有機生產標準禁止使用大多數合成農藥,但水果、蔬菜、堅果和出口特種作物的生產商正擴大採用生物農藥,以符合最大殘留限量(MRL)要求和零售商的永續發展計劃。生物農藥也被納入傳統農業系統,作為綜合蟲害管理(IPM)策略的一部分,以在保持作物產量的同時減少化學殘留。根據美國農業部經濟研究局(ERS)的數據顯示,2024年美國有機食品銷售額達到創紀錄的654億美元。這反映了消費者對有機食品需求的持續成長,並支持了有機生產系統的擴張。這一趨勢正在推動高價值作物整體生物農藥,從而鞏固美國生物農藥市場的長期成長。
美國生物農藥市場的發展主要得益於主流種植系統中生技藥品的日益普及。發表在《昆蟲科學前沿》(Frontiers in Insect Science)上的一項2025年調查顯示,2024年有45%的農作物種植戶使用生技藥品,比前兩年成長了8個百分點。該調查還顯示,63%的主要農業零售商報告稱,2024年生技藥品的銷售額有所成長。在受抗Bt玉米根蟲影響的地區,種子處理和針對大豆銹病的葉面噴布方案表明,生物來源產品的作用正在有機農業之外不斷擴大。在東南部的棉花種植計畫中,生物來源殺菌劑被用來防治幼苗病害,生物來源殺蟲劑被用來防治抗擬除蟲菊酯類殺蟲劑的小菜蛾。獲准在多種作物上註冊的芽孢桿菌類產品,只需一個標籤即可,這可以降低每英畝的註冊成本,並擴大產品在玉米、大豆和特種作物系統中的應用範圍。
與傳統化學農藥相比,生物農藥較高的單位面積成本是其推廣應用的主要障礙,尤其是在利潤率相對較低的大規模田間作物。微生物生物農藥通常需要專門的發酵、配製和品管流程,這增加了生產成本。此外,某些生物來源產品在特定的田間條件下可能需要更頻繁地施用才能維持藥效。因此,除非能夠證明其具有明顯的經濟效益,否則種植玉米、大豆和小麥等作物的種植者可能不願意放棄成本較低的合成農藥。雖然預計未來國內發酵能力、菌株開發和生產效率的提高將降低生產成本,但價格競爭力仍然是一項挑戰。因此,美國生物農藥市場的供應商需要透過證明其產品具有可衡量的價值來證明其高昂的加工成本是合理的,例如提高產量、控制抗藥性、符合殘留標準或進入高階市場。
到2025年,生物殺菌劑將占美國生物農藥市場佔有率的49.0%,成為最大的產品類別。其應用主要集中在種子處理、土壤灌溉以及作物、果樹、蔬菜和特種作物的葉部病害防治等領域。生物殺菌劑在認證有機農業中已廣泛應用,並且擴大被引入傳統農業系統,用於防治病害,同時確保符合殘留限量和抗性管理策略。它們在控制大豆猝死症候群、玉米苗期枯萎病和棉花立枯絲核菌症方面的顯著作用鞏固了其市場地位。相較之下,生物除草劑和其他產品類型的市場規模仍然較小,因為在不同的氣候和農業條件下實現穩定的雜草控制仍然是一項技術挑戰。
預計2026年至2031年間,生物農藥細分市場將以15.0%的複合年成長率成長,成為美國生物農藥市場中成長最快的細分市場。這一成長主要得益於市場對新型作用機制產品的需求不斷成長,以應對殺蟲劑抗藥性問題並支持綜合蟲害管理(IPM)項目。產品創新和法規核准的持續推進也增強了該細分市場的商業性潛力。 2026年2月,Vestaron公司的BASIN產品獲得美國環保署(EPA)批准,可用於戶外農業,防治鱗翅目昆蟲和軟體動物。這項進展拓展了生物防治的選擇範圍,並將推動美國生物農藥市場的持續成長。
According to Mordor Intelligence, the United States biopesticides market size was valued at USD 1.86 billion in 2025 and is estimated to grow from USD 2.10 billion in 2026 to USD 3.82 billion by 2031, at a CAGR of 12.7% during the forecast period (2026-2031).

This report is Segmented by Form (Biofungicides, Bioherbicides, and More) and by Crop Type (Cash Crops, Horticultural Crops, and Row Crops). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Metric Tons).
The expansion of organic farming and increasing demand for residue-compliant agricultural products are driving the adoption of biopesticides in the United States. Organic production standards prohibit most synthetic pesticides, while export-oriented fruit, vegetable, tree nut, and specialty crop growers are increasingly incorporating biological crop protection products to comply with maximum residue limit (MRL) requirements and retailer sustainability programs. Biopesticides are also being integrated into conventional farming systems as part of integrated pest management (IPM) strategies to reduce chemical residues while maintaining crop productivity. According to the United States Department of Agriculture (USDA) Economic Research Service (ERS), United States organic food sales reached a record USD 65.4 billion in 2024, reflecting continued growth in consumer demand for organically produced food and supporting the expansion of organic production systems. This trend is encouraging wider adoption of biopesticides across high-value crops, strengthening long-term growth in the United States biopesticides market.
The United States biopesticides market is supported by broader adoption of biological products across mainstream cropping systems. A 2025 Frontiers study in Insect Science reported that 45% of row-crop producers used biologicals in 2024, an increase of 8 percentage points from past 2 years. The same study found that 63% of leading agricultural retailers reported biological product sales growth during 2024. Seed treatments for Bt-resistant corn rootworm areas and foliar programs for soybean rust indicate that biological products are gaining roles beyond organic production. Southeast cotton programs are incorporating biofungicides for seedling disease management and bioinsecticides for bollworm populations with pyrethroid resistance. Bacillus-based products registered for multiple crops under a single label can reduce registration costs per acre and expand product access across corn, soybean, and specialty-crop systems.
The higher per-acre cost of biopesticides compared with conventional chemical pesticides remains a key barrier to adoption, particularly in broad-acre row crops where profit margins are relatively low. Microbial biopesticides often require specialized fermentation, formulation, and quality-control processes that increase production costs, while certain biological products also require more frequent applications to maintain efficacy under field conditions. As a result, growers in crops such as corn, soybean, and wheat may be reluctant to replace lower-cost synthetic pesticides unless clear economic benefits are demonstrated. Although improvements in domestic fermentation capacity, strain development, and manufacturing efficiency are anticipated to reduce production costs over time, price competitiveness remains a challenge. Consequently, suppliers in the United States biopesticides market must demonstrate measurable value through yield protection, resistance management, residue compliance, or premium market access to justify the higher treatment cost.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Biofungicides accounted for 49.0% of the United States biopesticides market share in 2025, making them the largest product segment. Their widespread adoption is driven by applications in seed treatment, soil drench, and foliar disease management across row crops, fruits, vegetables, and specialty crops. Biofungicides are widely used in certified organic production and increasingly integrated into conventional farming systems to manage diseases while supporting residue compliance and resistance-management strategies. Their established role in controlling soybean sudden death syndrome, corn seedling diseases, and cotton Rhizoctonia has reinforced their commercial position. By contrast, bioherbicides and other product categories remain smaller because achieving consistent weed control under diverse climatic and agronomic conditions continues to be a technical challenge.
Bioinsecticides are projected to expand at a 15.0% CAGR between 2026 and 2031, making them the fastest-growing product segment in the United States biopesticides market. Growth is driven by increasing demand for alternative modes of action to address insecticide resistance and support integrated pest management (IPM) programs. Product innovation and regulatory approvals continue to strengthen the segment's commercial potential. In February 2026, Vestaron received United States Environmental Protection Agency (EPA) approval for BASIN for outdoor agricultural use against lepidopteran pests and soft-bodied insects. This development expands biological insect-control options and supports the continued growth of the United States biopesticides market.